Kevin Noonan

McDonnell Boehnen Hulbert & Berghoff

300 S Wacker Dr

#3100

Chicago, IL 60606

United States

http://https://www.mbhb.com/

SCHOLARLY PAPERS

5

DOWNLOADS

266

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (5)

1.

Biotechnology Patent Law Top Ten of 2018 - Broad Wins, Sovereignty Loses, and Patents Dance

Akron Law Review, Vol. 52:637, 2019
Number of pages: 60 Posted: 10 Jul 2019 Last Revised: 06 Aug 2019
Kevin Noonan and Andrew W. Torrance
McDonnell Boehnen Hulbert & Berghoff and University of Kansas School of Law
Downloads 95 (499,074)
Citation 1

Abstract:

Loading...

biotechnology, biotech, patent, obviousness, patentable subject matter, sovereign immunity, inter partes review, CRISPR, biosimilar, patent dance, inequitable conduct, infringement, combination invention

2.

Biotechnology Patent Law Top Ten of 2019: Secret Sales, Denied Appeals, and the Promise of Coronavirus Cures

University of New Hampshire Law Review, Vol. 19, No. 2, 2021
Number of pages: 62 Posted: 28 Apr 2021
Kevin Noonan and Andrew W. Torrance
McDonnell Boehnen Hulbert & Berghoff and University of Kansas School of Law
Downloads 75 (575,795)

Abstract:

Loading...

biotechnology patent law, biotechnology, patent, 2019, litigation, enablement, novelty, obviousness, written description, best mode, doctrine of equivalents, interference, prosecution history estoppel

3.

Biotechnology Patent Law Top Ten of 2020: Valeant Victorious, Falling Eagle, and Successful Slayback

8 Tex. A&M J. Prop. L. 409-472 (2022)
Number of pages: 64 Posted: 27 May 2022
Andrew W. Torrance and Kevin Noonan
University of Kansas School of Law and McDonnell Boehnen Hulbert & Berghoff
Downloads 42 (756,784)

Abstract:

Loading...

biotechnology patent law, biotechnology, patent, 2020, litigation, enablement, novelty, obviousness, written description, best mode, doctrine of equivalents, interference, prosecution history estoppel, infringement, inducement, ANDA, patentable subject matter, common ownership, CRISPR, CoVID-19

4.

Biotechnology Patent Law Top Ten of 2021 Experimentation, Blaze Marks, and Unspecified Ranges

Santa Clara Computer and High Technology Law Journal, Vol. 38, 2022
Number of pages: 82 Posted: 06 Mar 2023
Kevin Noonan and Andrew W. Torrance
McDonnell Boehnen Hulbert & Berghoff and University of Kansas School of Law
Downloads 36 (800,277)

Abstract:

Loading...

patent, intellectual property, biotechnology, vaccine, COVID-19, pandemic, Moderna, BioNTech, Pfizer, Patent Trial and Appeal Board, PTAB, post-grant review, inter partes review, written description, anticipation, nonobviousness, enablement, claim construction, skinny label, monoclonal antibodies

5.

Biotechnology Patent Law Top Ten of 2022: Inducement, Clear Error, and Interferences Galore

26 SMU Science and Technology Law Review 317
Number of pages: 65 Posted: 10 Jan 2024
Andrew W. Torrance and Kevin Noonan
University of Kansas School of Law and McDonnell Boehnen Hulbert & Berghoff
Downloads 18 (959,683)

Abstract:

Loading...

Biotechnology, Patent, Inducement, Clear Error, Interference, CRISPR-Cas9, Genome Editing, SARS-CoV-2, Pandemic, Genetic Diseases, Diagnostic Methods, Patentable Subject Matter, Federal Circuit, ANDA, Section viii Carve-out, Patentable Subject Matter